Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1986-04-01
1988-06-21
Brown, J. R.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 15, 514885, A61K 3702
Patent
active
047526017
ABSTRACT:
A method of modulating immune complex mediated immune responses in mammals is described, comprising administering a peptide comprising the amino acid sequence
REFERENCES:
patent: 3778426 (1973-12-01), Najjar
patent: 3873511 (1975-03-01), Otsuka et al.
patent: 3972773 (1976-08-01), Isowa et al.
patent: 4353823 (1982-10-01), Chipens et al.
patent: 4415493 (1983-11-01), Weigle et al.
patent: 4579840 (1986-04-01), Hahn
Martinez et al., Chemical Abstracts, 100, 639 (1984), abst. No. 68694t.
Martinez et al., Chemical Abstracts, 99, 461 (1983), abst. No. 156528h.
Barnett-Foster et al., Mol. Immunol., 19, 407 (1982).
Barnett-Foster et al., J. Immunol., 120, 1952 (1978).
Bich-Thuy, J. Immunol., 129, 150 (1982).
Boackle et al., Nature, 282, 742 (1979).
Burton et al., Nature, 288, 388 (1980).
Calder et al., Clin. Exp. Immunol., 14, 153 (1973).
Ciccimarra et al., Proc. Natl. Acad. Sci., USA, 72, 2081 (1975).
Cochrane et al., Lancet, 1, 441 (1976).
Dorrington et al., Immunol. Rev., 41, 3 (1978).
Douvas, Ann. Immunol. Inst. Pasteur, 132C, 307 (1981).
Fantone, J. Pathol., 107, 397 (1982).
Fehr et al., N. Engl. J. Med., 306, 1254 (1982).
Fischer et al., J. Immunol., 126, 1452 (1981).
Fridman et al., Immunol. Rev., 56, 51 (1981).
Goeken et al., Hum. Immunol. 6, 79 (1983).
Gonzalez-Molina et al., J. Clin. Invest., 59, 616 (1977).
Goodwin, Clin. Immunol. Immunopath., 15, 106 (1980).
Halstrom et al., Chemical Abstracts, 80, 461 (1974).
Hamburger, Science, 189, 389 (1975).
Hamburger, Immunology, 38, 781 (1979).
Hibi et al., Clin. Exp. Immunol., 49, 75 (1982).
Holdsworth, J. Immunol., 130, 735 (1983).
Goodwin et al., Chemical Abstracts, 80, 461 (1974).
Imbach et al., Lancet, 1228 (Jun. 6, 1981).
James et al., J. Clin. Invest., 66, 1305 (1980).
Jasani et al., J. Biochem., 181, 623 (1979).
Johnson et al., J. Immunol., 117, 1491 (1976).
Kabelitz et al., Eur. J. Immunol., 12, 687 (1982).
Klein et al., Immunol., 48, 337 (1983).
Kolsch et al., Immunol. Rev., 49, 61 (1980).
Kuehl et al., Science, 210, 978 (1980).
Kumar, Pathologic Basis of Disease (eds. S. L. Robbins & R. S. Cotran), 304, (W. B. Saunders, Philadelphia, 1979).
Lawrence et al., N. Engl. J. Med., 302, 1186 (1980).
Leung et al., J. Immunol., 129, 1742 (1982).
Lukas et al., J. Immunol., 127, 2555 (1981).
McMillan, N. Engl. J. Med., 304, 1135 (1981).
Melwicz et al., Clin. Exp. Immunol., 49, 364 (1982).
Merrifield, J. Am. Chem. Soc., 85, 2149 (1963).
Miyasaka, J. Clin. Invest., 66, 928 (1980).
Morgan et al., Proc. Natl. Acad. Sci. USA, 79, 5388 (1982).
Oberbarnscheidt et al., Immunol., 35, 151 (1978).
Perez et al., Textbook Rheumatology, vol. I, 179-194, W. B. Saunders, Philadelphia, 1981.
Perez-Montfort, Mol. Immunol., 19, 1113 (1982).
Plummer et al., Fed. Proc., 42, 713 (1983).
Prystowsky et al., Biochemistry, 20, 6349 (1981).
Ratcliff et al., Immunol. Lett., 4, 215 (1982).
Sakane et al., Proc. Natl. Acad. Sci. USA, 75, 3464 (1978).
Samuelsson, Science, 220, 568 (1983).
Scott et al., Fed. Proc., 42, 129 (1983).
Smith, et al., J. Natl. Cancer Inst., 58, 579 (1977).
Smolen, et al., J. Immunol., 129, 1050 (1982).
Stanworth, Mol. Immunol., 19, 1245 (1982).
Stanworth, et al., J. Biochem., 180, 665 (1979).
Stenson, et al., J. Immunol., 125, 1 (1980).
Striker, J. Exp. Med., 149, 127 (1979).
Takatsu, et al., J. Immunol., 114, 1838 (1975).
Veretennikova, et al., Int. J. Peptide Protein Res., 17, 430 (1981).
Weiss, et al., J. Immunol., 129, 309 (1982).
Brown J. R.
Immunetech Pharmaceuticals
Moezie F. T.
LandOfFree
Method of blocking immune complex binding to immunoglobulin FC r does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of blocking immune complex binding to immunoglobulin FC r, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of blocking immune complex binding to immunoglobulin FC r will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-929997